Legal Representation
Attorney
Siu K. Lo
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 4, 2014 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Jan 27, 2014 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| Jan 27, 2014 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Dec 11, 2013 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | Loading... |
| Sep 3, 2013 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | Loading... |
| Sep 3, 2013 | GNSF | O | SUBSEQUENT FINAL EMAILED | Loading... |
| Sep 3, 2013 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | Loading... |
| Aug 7, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 7, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 7, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 7, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 7, 2013 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 7, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 25, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 25, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 24, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 22, 2013 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jan 22, 2013 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Jan 22, 2013 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Jan 22, 2013 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Jul 22, 2012 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 22, 2012 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 22, 2012 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jun 7, 2012 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 7, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 7, 2011 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 7, 2011 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 7, 2011 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Nov 23, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 23, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 23, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 23, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 23, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2011 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Feb 22, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development in the pharmaceutical and biotechnology fields, specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding body donation research
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the literal elements "A MEMBER OF BIOTECHNOLOGY GROUP" and the sylized term "GENESIS" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letters "GENES" and "S" in "GENESIS"; the color beige appears in the fourteen spheres representing atoms; the color black appears in the literal elements "A MEMBER OF BIOTECHNOLOGY GROUP", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.
Color Claim
The color(s) maroon, beige, black and white is/are claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTECHNOLOGY GROUP"